All Stories

  1. Patients with High Priority for Kidney Transplant Who Are Not Given Expedited Placement on the Transplant Waiting List Represent Lost Opportunities
  2. Failure to Advance Access to Kidney Transplantation over Two Decades in the United States
  3. Building an Ideal Quality Metric for ESRD Health Care Delivery
  4. Emergency Department Visits after Kidney Transplantation
  5. Implantable Cardioverter-Defibrillators in Patients with CKD: A Propensity-Matched Mortality Analysis
  6. Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference
  7. Behavioral Stage of Change and Dialysis Decision-Making
  8. Low Testosterone at Time of Transplantation is Independently Associated with Poor Patient and Graft Survival in Male Renal Transplant Recipients
  9. Association between Kidney Transplant Center Performance and the Survival Benefit of Transplantation Versus Dialysis
  10. Serum Testosterone Levels and Mortality in Men With CKD Stages 3-4
  11. Association Between Liver Transplant Center Performance Evaluations and Transplant Volume
  12. Does the UNOS Heart Transplant Allocation System Favor Men Over Women?
  13. Simulating the New Kidney Allocation Policy in the United States
  14. Clinical Research Methods and Analysis in Organ Transplantation
  15. Performance comparisons in major uro‐oncological surgeries between the USA and Japan
  16. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999–2004
  17. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease
  18. Changing Our Prior Assumptions: Adapting to New Bayesian Transplant Center Report Cards
  19. Low-Dose Rapamycin (Sirolimus) Effects in Autosomal Dominant Polycystic Kidney Disease: An Open-Label Randomized Controlled Pilot Study
  20. MP32-16 LOW TOTAL TESTOSTERONE IS ASSOCIATED WITH HIGHER MORTALITY IN MEN WITH STAGES 3-4 CHRONIC KIDNEY DISEASE
  21. Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension
  22. Hospitalizations Following Living Donor Nephrectomy in the United States
  23. Response: old-to-old pancreas transplantation, what's old in the USA may be young in Europe
  24. Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney–Pancreas Transplantation
  25. Chronic Kidney Disease in an Electronic Health Record Problem List: Quality of Care, ESRD, and Mortality
  26. Considerations of Reliability and Validity of Transplant Center Report Cards
  27. CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation
  28. The Decline in Living Kidney Donation in the United States
  29. The authors reply
  30. Outcomes of Patients Receiving Maintenance Dialysis Admitted Over Weekends
  31. Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3-4 in a Clinical Population
  32. Comorbidity Burden and Perioperative Complications for Living Kidney Donors in the United States
  33. Alemtuzumab induction in simultaneous pancreas and kidney transplantation
  34. Outcomes and survival analysis of old-to-old simultaneous pancreas and kidney transplantation
  35. The Prognostic Value of Kidney Transplant Center Report Cards
  36. The Burden of Proof in the Design of Early Phase Clinical Trials
  37. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation
  38. Electronic health records: a new tool to combat chronic kidney disease?
  39. Metabolic Syndrome, ESRD, and Death in CKD
  40. Prevalence of Copied Information by Attendings and Residents in Critical Care Progress Notes*
  41. Community Risk Factors: Powerful Independent Predictors of Kidney Transplant Recipient Outcomes
  42. Graft Survival from Kidney Recipients Primary Transplant: a Powerful Predictor for Re-Transplant Survival
  43. External Validity in Solid Organ Transplantation Research: Are Ethical Practices Compromised?
  44. 80-P
  45. Sex Differences in Mortality on Waiting List for Heart Transplantation
  46. The Association of Community Health Indicators With Outcomes for Kidney Transplant Recipients in the United States
  47. Increasing the pool of deceased donor organs for kidney transplantation
  48. Predictive Models for Acute Kidney Injury Following Cardiac Surgery
  49. Obesity, Anthropometric Measures and Chronic Kidney Disease Complications
  50. Influence of CIT-Induced DGF on Kidney Transplant Outcomes
  51. Low 25-Hydroxyvitamin D Levels and Mortality in Non–Dialysis-Dependent CKD
  52. Significant Potential Utility for Donor Yield Models: But Proceed With Caution
  53. Patient Participation in Research Among Solid Organ Transplant Recipients in the United States
  54. Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes
  55. 2063 WHEN IS A ZERO MISMATCHED KIDNEY TRANSPLANT REALLY A ZERO MISMATCH?
  56. Strength in numbers—predicting long-term transplant outcomes
  57. Import Kidney Transplants from Nonmandatory Share Deceased Donors: Characteristics, Distribution and Outcomes
  58. Glomerular Filtration Rate Slopes Have Significantly Improved Among Renal Transplants in the United States
  59. Conversion from Diagnostic Laparoscopy to Laparotomy: Risk Factors and Occurrence
  60. Quantitative Aspects of Clinical Reasoning: Measuring Endpoints and Performance
  61. Outcomes of Kidney and Pancreas Transplantation
  62. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age
  63. Hidden Selection Bias Deriving From Donor Organ Characteristics Does Not Affect Performance Evaluations of Kidney Transplant Centers
  64. Response: DonorNet and the Potential Effects on Organ Utilization
  65. Single Kidney Transplantation from Young Pediatric Donors in the United States
  66. Incidence, Clinical Predictors, Genomics, and Outcome of Acute Kidney Injury Among Trauma Patients
  67. GFR SLOPES HAVE SIGNIFICANTLY IMPROVED AMONG RENAL TRANSPLANTS IN THE US
  68. The Elephant in the Room: Failings of Current Clinical Endpoints in Kidney Transplantation
  69. Acute kidney injury and long-term outcomes: more to learn
  70. 2071 THE EVOLVING OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS OVER 70 YEARS OF AGE
  71. Outcomes of Renal Transplantation
  72. Metabolic Syndrome and Mild to Moderate Chronic Kidney Disease Among Minorities
  73. Evaluation of pacing site in dogs with naturally occurring complete heart block
  74. The Success of Continued Steroid Avoidance After Kidney Transplantation in the US
  75. Single Kidney Transplantation from Young Pediatric Donors in the United States
  76. CMS oversight, OPOs and transplant centers and the law of unintended consequences
  77. AZA/Tacrolimus Is Associated with Similar Outcomes as MMF/Tacrolimus among Renal Transplant Recipients
  78. Comparable Barriers to Access to Kidney Transplantation Across National Lines
  79. A Lifetime Versus a Graft Life Approach Redefines the Importance of HLA Matching in Kidney Transplant Patients
  80. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States
  81. Effects of Blood Transfusions Given After Renal Transplantation
  82. Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery
  83. Long-Term Risk of Mortality and Acute Kidney Injury During Hospitalization After Major Surgery
  84. Neural networks for predicting graft survival
  85. The Pivotal Impact of Center Characteristics on Survival of Candidates Listed for Deceased Donor Kidney Transplantation
  86. Statistical Notations
  87. Uric Acid: A Novel Risk Factor for Acute Kidney Injury in High-Risk Cardiac Surgery Patients?
  88. Design and Analysis of Clinical Trials in Transplantation: Principles and Pitfalls
  89. The Practical Utility of an Economic Analysis of Calcineurin Withdrawal following Renal Transplantation
  90. KIDNEY TRANSPLANT LISTING FOLLOWING, LIVER, HEART AND LUNG TRANSPLANTATION
  91. The Association of Candidate Mortality Rates With Kidney Transplant Outcomes and Center Performance Evaluations
  92. Deceased Donor Kidney and Liver Transplantation to Nonresident Aliens in the United States
  93. Interventional Trials Involving Patients Cannot Be Performed Safely Without a Control Group Treated With the Standard of Care
  94. Mycophenolate mofetil: long-term outcomes in solid organ transplantation
  95. Renal transplantation in the elderly
  96. Prediction Models Assessing Transplant Center Performance: Can a Little Knowledge be a Dangerous Thing?
  97. Kidneys From Deceased Donors: Maximizing the Value of a Scarce Resource
  98. Interleukin 12 Is Associated with Reduced Relapse without Increased Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
  99. The Impact of Pretransplant Dialysis on Outcomes in Renal Transplantation
  100. The Impact of Mycophenolate Mofetil on Long-Term Outcomes in Kidney Transplantation
  101. Access to Quality
  102. A 10-year Analysis of Organ Donation after Cardiac Death in the United States
  103. Sirolimus in Combination with Tacrolimus Is Associated with Worse Renal Allograft Survival Compared to Mycophenolate Mofetil Combined with Tacrolimus
  104. Increased Levels of Tumor Necrosis Factor α Are Associated with an Increased Risk of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
  105. The effects of renal transplantation on peripheral blood dendritic cells
  106. Are We Frozen in Time? Analysis of the Utilization and Efficacy of Pulsatile Perfusion in Renal Transplantation
  107. Kidneys from Deceased Donors: Maximizing the Value of a Scarce Resource
  108. The Broad Spectrum of Quality in Deceased Donor Kidneys
  109. Preservation of Long-term Renal Allograft Survival: A Challenge for the Years to Come
  110. Circulating endothelial cells are associated with future vascular events in hemodialysis patients
  111. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease
  112. Effect of Sirolimus Withdrawal in Patients with Deteriorating Renal Function
  113. Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End-Stage Renal Diseas
  114. Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?
  115. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era
  116. Poor Predictive Value of Serum Creatinine for Renal Allograft Loss
  117. Overview of Large Database Analysis in Renal Transplantation
  118. Evaluation criteria for report cards of healthcare providers